> Skip repeated content

Development and Testing of the Hand Surgery Expectations Survey

IRB Number: 10021

March 17, 2010

Institutional Review Board, Hospital for Special Surgery

The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.

For further information, see Understanding Clinical Trials/Research Studies.

Principal Investigator

Lana Kang, MD


Edward A. Athanasian, MD
Michelle G. Carlson, MD
Carol Mancuso, MD
Andrew J. Weiland, MD
Scott W. Wolfe, MD
Steve K. Lee, MD


The phenomenon to be studied is the expectations of patients seeking treatment for basilar joint arthritis of the hand. The basilar joint refers to the thumb carpometacarpal joint and is the most common site of arthritis treated with surgical methods.  The main reasons for seeking treatment for basilar joint arthritis are to relieve symptoms and improve function.   The study aim is to develop and to test a validated survey that measures patients’ expectations after treatment for basilar joint arthritis.  The primary form if intervention is a one-on-one interview via which data will be obtained and collected.  There will be 3 parts of the study, and the total number of patients needed for the study is 163. 

Inclusion/Exclusion Criteria

Adult English speaking patients age 18-100 seeking treatment for basilar joint arthritis

Contact Information

Lana Kang, MD